Parallax Volatility Advisers, L.P. Aclaris Therapeutics, Inc. Transaction History

Parallax Volatility Advisers, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$7.07 - $17.95 $342,428 - $869,390	48,434 New	48,434 $391,000
Q2 2019 Aug 14, 2019	SELL	$2.13 - $7.06 $23,643 - $78,366	-11,100 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$5.63 - $7.84 $18,579 - $25,872	3,300 Added 42.31%	11,100 $66,000
Q4 2018 Feb 14, 2019	BUY	$6.3 - $15.4 $49,140 - $120,120	7,800 New	7,800 $58,000
Q1 2018 May 15, 2018	SELL	$17.08 - $25.64 $59,540 - $89,381	-3,486 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$21.47 - $27.8 $74,844 - $96,910	3,486	3,486 $86,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.